Results 251 to 260 of about 43,186 (297)

Psychotropic Drugs in Internal Medicine.

Archives of Internal Medicine, 1970
The Excerpta Medica Foundation has taken on the task of publishing complete proceedings from various international congresses. The present volume is 182 in this series. This symposium was held in May 1968, so that publication delay has been no more than usual. The resulting product is a slim, slick book which commands a high price for its size.
openaire   +1 more source

Psychotropic Drugs Reemerging as Headache Medicines

CNS Drugs
Scientific and public attention on the therapeutic effects of psychedelics and other psychoactive compounds in headache disorders has recently grown. The use and reported therapeutic effects of such treatments have long been reported, though formal clinical trials are only recently taking place.
openaire   +2 more sources

Psychotropic medicine prescriptions in Italian youths: a multiregional study

European Child & Adolescent Psychiatry, 2015
The aim of the study was to evaluate the trend of paediatric psychotropic drug prescriptions in Italy. Data sources were regional, outpatient prescription databases. Seven Italian regions, covering 50 % of the Italian population, provided data from 2006 to 2011. Prevalence and incidence of prescriptions by age and gender were evaluated for psychotropic,
Daniele, Piovani, Antonio, Clavenna, Massimo, Cartabia, Maurizio, Bonati   +3 more
openaire   +2 more sources

Regulatory and clinical aspects of psychotropic medicinal products bioequivalence

European Neuropsychopharmacology, 2015
Introduction of generic medicinal products to the market has increased access to modern therapies but also enabled significant reduction in their cost, leading to containment of public expenditures on medicinal products reimbursement. The critical assessment of bioequivalence of any reference medicinal product and its counterpart is based on comparison
Ewa, Bałkowiec-Iskra, Grzegorz, Cessak, Olga, Kuzawińska, Katarzyna, Sejbuk-Rozbicka, Konrad, Rokita, Dagmara, Mirowska-Guzel   +5 more
openaire   +2 more sources

Regulatory meta-analyses for the evaluation of psychotropic medicines

The Lancet Psychiatry, 2017
[no abstract available]
BARBUI, Corrado, PURGATO, Marianna, OSTUZZI, Giovanni   +2 more
openaire   +2 more sources

Psychotropic medication—insights from evolutionary medicine

2015
The therapeutic options for psychiatric disorders have been dramatically advanced by the development of medication for almost all conditions. However, personalized treatment approaches need to carefully consider costs (potential harm) and benefits. All psychotropic drugs have side-effects in relevant areas of life, including social play (stimulants ...
openaire   +1 more source

Enhancing treatment with psychotropic medicines.

Bulletin of the Menninger Clinic, 1994
Psychiatric treatment of persons with severe, recurring, or chronic disorders of mood, cognition, or behavior is increasingly provided in ambulatory settings where control of treatment shifts to the patient. Medicines are a fundamental component in the effective, comprehensive care of such severely ill patients, and often are required for prolonged ...
openaire   +1 more source

Use of psychotropic medicines in mental health care

2018
Introduction This chapter provides an overview of the common medicines prescribed within mental health care and explores the ways in which personal narratives and social expectations can influence the experience of taking medicines.
Mark Loughhead, Simon Bell, Nicholas Procter   +2 more
openaire   +2 more sources

[Psychotropic effects of Sino-Japanese traditional medicines].

Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology, 1993
Recently there are a number of clinical reports that Sino-Japanese traditional medicines have good effects on patients with anxiety and/or depression. To detect the clinical efficacy of those medicines, we have examined those effects on various behavioral changes induced by stress in experimental animals.
openaire   +1 more source

[How to use psychotropic medicine in women].

Nihon rinsho. Japanese journal of clinical medicine, 2012
It's very important to know how to use psychotropic medicine, especially selective serotonin reuptake inhibitors in pregnant women. Because between 14% and 23% of pregnant women will experience a depressive disorder while pregnant. In 2003, approximately 13% of women took an antidepressant at some point in pregnancy, a rate that has doubled since 1999.
openaire   +1 more source